The particulate enzyme fraction from mung bean (Phaseolus aureus) seedlings catalyzes the incorporation of mannose from GDP-[14Clmannose into mannosyl-phosphoryl-dolichol and of N-acetylglucosamine from UDP-13HIN-acetylglucosamine into N-acetylglucosanine-pyrophosphoryl-polyisoprenol. Bacitracin inhibits the transfer of both of these sugars into the lipid-linked saccharides with 50% inhibition being observed at 5 mM bacitracin. This antibiotic did not inhibit the transfer of glucose from UDP-1'4Clglucose into steryl glucosides or the incorporation of glucose into a cell wall glucan. Bacitracin also inhibited the in vivo incorporation of I14Clmannose into mannosyl-phosphoryl-dolichol and into glycoprotein by carrot (Daucus carota) slices. While bacitracin also inhibited the incorporation of lysine into proteins by these slices, protein synthesis was less sensitive than glycosylation. Thus at 2 mM bacitracin glycosylation was inhibited 92%, while protein synthesis was inhibited only 50%.
Bacitracin is a polypeptide antibiotic produced by Bacillus licheniformis, which has been shown to act on bacteria by interfering with the formation of lipid-linked sugars which are involved in peptidoglycan synthesis (10, 12) . There is evidence that this interference is the result of the formation of a complex between bacitracin, the undecaprenyl-pyrophosphate, and a divalent cation (11) . The undecaprenyl-pyrophosphate, thus bound, cannot be dephosphorylated to regenerate the undecaprenyl-monophosphate which is necessary to form lipid-sugar intermediates. This binding of phospholipids may also explain the observation that bacitracin disrupts the cell membrane (13) .
That lipid-linked sugars act as intermediates in the biosynthesis of polysaccharides and glycoproteins has been well established in plants and animals as well as bacteria (4, 6, 9, 14) . Figure I is a diagram of a postulated series of reactions to explain the biosynthesis of glycoproteins in eucaryotic cells. Since the lipids involved in the above reactions are polyprenyl-phosphates and are probably derived from polyprenyl-pyrophosphates, it is reasonable to expect plant and animal cells to be sensitive to bacitracin. Recent work done on calf microsomes (8) indicated that bacitracin did interfere with the formation of the GlcNac2-pyrophosphoryl-dolichol intermediate but had little effect on the formation of mannosyl-phosphoryl-dolichol. We liquid scintillation spectrometer using scintillation fluid containing 500 ml of Triton X-100, 500 ml of toluene, 5 g of PPO and 0.2 g of POPOP.
Plant Material. Mung bean seeds and carrot roots were purchased in local supermarkets and stored at 4 C. Seeds of Phaseolus aureus (mung beans) were sterilized for 5 min in commercial bleach diluted 1:10 (about 0.5% hypochlorite) and rinsed with distilled H20. They were then planted in moist Vermiculite and allowed to grow in the dark for 40 hr. The in vivo experiments were performed using thin discs (I mm in thickness and 9 mm in diameter) of carrot phloem parenchyma preincubated for 16 hr in water at 27 C.
Preparation of Particulate Enzyme. Hypocotyls from mung bean sprouts were ground in cold buffer (5 for various lengths of time at several bacitracin concentrations in H20 in a final volume of 5 ml. Reactions were terminated by the addition of 10 ml of CHCl3/CH3OH (1:1). The carrots were then ground in an Omni-Mix grinder, mixed vigorously, and the phases were separated by centrifugation. The lower, organic phase was removed and saved. The upper, aqueous phase and interface was extracted a second time with S ml of CHCl:3. After separation of the phases, the lower layer was removed and combined with the first organic phase. The combined organic phases were extracted with CHCl:3/CH3OH/H20 (3:48:47) and the lower phase was removed and dried in scintillation vials for radioactive measurements. The upper, aqueous layer from the original extraction was then centrifuged to isolate the pellet which was washed extensively with 100%o methanol, 50%o methanol, and H20. After washing, the pellet was treated with 5 (4, 6) . The addition of bacitracin to such incubation mixtures greatly inhibited this formation of labeled glycolipids (Fig. 2) . As shown in Figure 2 , the incorporation of both labeled mannose and labeled GIcNAc from their respective nucleotide sugars into lipid-soluble material was inhibited approximately 50%o (mannose was actually 43% inhibited and GlcNAc 50%) at a bacitracin concentration of 5 mm and about 80% at a bacitracin concentration of 10 mm. The decrease in lipid-soluble radioactive products, in the presence of bacitracin, was not due to an effect of bacitracin on the partitioning of lipid products. That is, bacitracin did not block the extraction of lipids from reaction mixtures. Thus, reaction mixtures in which the bacitracin was added at the end of the incubation showed no decrease in lipid-soluble radioactivity when compared to the controls with no bacitracin (data not shown). The inhibition by bacitracin was followed during the course of a 20-min incubation as shown in Figure 3 . It can be seen that inhibition was observed as early as I min after the start of the incubation and persisted throughout the 20-min incubation. The formation of mannosylphosphoryl-dolichol was inhibited approximately 40o at 4 ,umol of bacitracin while the synthesis of GlcNAc-pyrophosphorylpolyisoprenol was inhibited about 55% at that concentration.
In order to show that bacitracin is a specific inhibitor of polyprenyl-linked sugars and not simply an inhibitor of the formation of glycolipids in general, the effect of bacitracin on the production of steryl glucosides was investigated. Enzyme preparations were incubated with UDP-[14C]glucose at bacitracin concentrations up to 30 mm and steryl glucoside formation was determined as previously described (7) . The incorporation of glucose into steryl glucoside was not inhibited at any bacitracin concentration, but mannose incorporation into mannosyl-phosphoryl-dolichol was inhibited as before (Fig. 4) .
The labeled glycolipid formed in the above experiments from UDP-glucose in the presence of bacitracin was subjected to TLC in two solvent systems. Only one peak of radioactivity was detected on thin layer plates run in both of these solvents and the RF values of this product were similar to those reported for steryl glucosides (7) .
Bacitracin, a suspected inhibitor of glycoprotein synthesis, was also found to have no effect on the formation of glucans from UDP-glucose (Fig. 4) . In this experiment, the incorporation of glucose from UDP-[14Cjglucose into cell wall glucan was assayed as previously described in the presence of increasing amounts of bacitracin (1) . This polymer was previously characterized as a Ii-1,3-glucan. Bacitracin did not affect the synthesis of this polymer except possibly at very high concentrations (Fig. 4) Figure SB , a labeled glycolipid was formed from ['4Cjmannose in carrot slices in the absence of bacitracin. The production of this labeled glycoplipid was almost completely inhibited when the bacitracin concentration of the surrounding media was 2 mm, while I mm bacitracin was somewhat less inhibitory. Concentrations up to 10 mm were used, although 2 mm is the highest concentration shown in the figure. The glycolipid formed in the absence of bacitracin was subjected to mild acid hydrolysis (0.01 M HC1 in 50% propanol at 100 C for 15 min). All of the radioactivity was released as water-soluble material which with production of mannosyl-phosphoryl-dolichol (O-O) at concentrations of bacitracin up to 30 mm. B: production of glucan polymer from UDP-['4Cjglucose in presence of bacitracin. Insoluble products, from incubations of mung bean particulate enzyme with UDP-I'4Clglucose, containing both glycoprotein and polysaccharide, were subjected to pronase digestion. The insoluble radioactive product which was not pronasedigestible was presumed to be glucan. mannosyl-phosphoryl-dolichol, and in vivo synthesis of this lipid is inhibited by bacitracin.
The effect of bacitracin on the synthesis and glycosylation of glycoprotein was also investigated. Insoluble material from the above reactions (containing both protein and polysaccharide material) was digested with pronase, and the amount of water-soluble radioactivity released by this treatment was measured. Figure 5A shows the amount of radioactivity released by pronase from the insoluble products of carrots incubated with [ 4C]mannose and 0, I mm or 2 mm bacitracin. It can be seen that bacitracin inhibited the incorporation of mannose into insoluble material that was digestible with pronase. Complete acid hydrolysis of this watersoluble material released all of the radioactivity as mannose suggesting that this sugar was incorporated intact into glycoproteins which were rendered water-soluble by pronase digestion.
Protein synthesis by carrot slices, in the presence or absence of bacitracin, was also studied by following the incorporation of radioactive lysine into trichloroacetic acid insoluble material.
The incorporation of ['4CJlysine into pronase-digestible material was less sensitive to bacitracin than was the incorporation of [14Cjmannose (Table I) . After 20 min, at a bacitracin concentration of 2 mm, the incorporation of mannose into insoluble material was inhibited 92%, whereas the incorporation of lysine into protein was inhibited only 50%.
DISCUSSION
In bacterial systems, bacitracin has been shown to inhibit the formation of undecaprenyl-pyrophosphoryl-sugars which are intermediates in peptidoglycan synthesis (10, 12) . Apparently bacitracin binds the undecaprenyl-pyrophosphate and prevents its dephosphorylation which is necessary for recycling of this lipid carrier (12, 13) . We have found that bacitracin also interferes with the formation of the lipid-linked saccharides which are intermediates in plant glycoprotein synthesis. Thus, this antibiotic inhibits the transfer of mannose from GDP-['4Cjmannose to mannosylphosphoryl-dolichol as well as the transfer of GIcNAc from UDP- These results are in contrast to those of Herscovics et al. (8) who reported that bacitracin blocked the formation of GlcNAcpyrophosphoryl-dolichol by microsomal preparations of calf pancreas, but had no effect on the synthesis of mannosyl-phosphoryldolichol. In mammalian systems, the lipid carrier for both mannose and GlcNAc has been reported to be a dolichol but in plants these two lipid carriers may be different. Thus the mannosecontaining lipid from Phaseolus vulgaris has been characterized by mass spectrometry as mannosyl-phosphoryl-dolichol (3). Although the lipid portion of the GlcNAc-containing lipid has not been chemically characterized in plants, studies from our laboratory suggest that this lipid is different from the dolichol which carries mannose (5) . In spite of the differences, it seems likely that the lipid to which the GlcNAc is attached is of the polyisoprenol type. It appears unlikely that these differences between the plant and animal lipids can explain the differences reported in bacitracin action, especially since this antibiotic also inhibits bacterial systems which involve lipids of the undecaprenol type. Further work will be necessary to explain the mode of action of this antibiotic. In oviduct tissue extracts, bacitracin was shown to cause the accumulation of the trisaccharide-lipid, mannose-13-GlcNAcGlcNAc-pyrophosphoryl-dolichol (2) .
Although bacitracin clearly inhibited the formation of mannosyl-phosphoryl-dolichol and GlcNAc-pyrophosphoryl-polyisoprenol, it has no effect on the transfer of glucose from UDP-['4Cjglucose to steryl glucosides. This was an interesting observation since it showed that bacitracin did not inhibit all in vitro reactions and more importantly that the antibiotic did not prevent the formation of neutral glycolipids such as steryl glucosides. Thus the antibiotic appears to have some specificity for phosphorylated lipids of the polyisoprenol type. Bacitracin also inhibited the in vivo incorporation of ['4C]mannose into mannosyl-phosphoryldolichol and into glycoprotein in carrot slices. In vitro 80o inhibition of mannose incorporation was seen at 10 mm bacitracin, whereas in vivo 70% inhibition was observed at 2 mm. This may indicate that the bacitracin concentration of the surrounding medium is different than that inside the cell. Bacitracin may accumulate in the cell or it could be that in vivo systems are more sensitive. Bacitracin also inhibited the incorporation of mannose into glycoprotein but did not block the transfer of glucose from UDP-glucose into /3, l1-3 glucan. Again, this showed that the antibiotic did not inhibit all glycosyl transferase reactions and also provided additional evidence for the role of mannosyl-phosphoryldolichol in the mannosylation of proteins.
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